Stockreport

Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK, April 24, 2020 /PRNewswire/ -- Voltron Therapeutics, Inc. announced today that it has selected the peptides required to complete the structure of HaloVax for d [Read more]